Andrew McDowell
Medical · New Haven, CTNPI 1376947432
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,649, more than ten times the $31 reported in 2022.
Across 178 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$603
- Madrigal Pharmaceuticals$579
- Ardelyx, Inc.$507
- Johnson & Johnson$419
- Gilead$343
- Takeda Pharmaceuticals U.S.A., Inc.$305
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,01398%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $603 |
| Madrigal Pharmaceuticals | 14 | $579 |
| Ardelyx, Inc. | 23 | $507 |
| Johnson & Johnson | 17 | $419 |
| Gilead | 21 | $343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $305 |
| Phathom Pharmaceuticals, Inc. | 15 | $301 |
| Lilly USA, LLC | 13 | $203 |
| Celltrion USA Inc. | 5 | $138 |
| Intercept Pharmaceuticals, Inc. | 4 | $102 |
| Ironwood Pharmaceuticals, Inc | 4 | $98 |
| Amgen | 3 | $89 |
| Pfizer | 6 | $87 |
| QOL Medical, LLC | 2 | $64 |
| Aimmune Therapeutics, Inc. | 2 | $58 |
| Exact Sciences | 2 | $46 |
| Medtronic | 1 | $31 |
| Organon | 1 | $24 |
| Novo Nordisk | 1 | $24 |
| Biocon Biologics Inc | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Invivyd Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,090 in reported general payments places this provider in the 85th percentile of 592 medical providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 189 | $138,022 |
| NucyntaTapentadol Hcl | 25 | $34,708 |
| Xtampza ErOxycodone Myristate | 42 | $28,548 |
| Nucynta ErTapentadol Hcl | 15 | $23,356 |
| Fentanyl | 196 | $19,920 |
| Oxycodone Hcl | 637 | $12,226 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 77 | $8,930 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 453 | $8,599 |
| Morphine Sulfate ErMorphine Sulfate | 291 | $7,661 |
| MovantikNaloxegol Oxalate | 23 | $7,585 |
| Buprenorphine | 26 | $7,116 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 219 | $5,444 |
| Methadone Hcl | 221 | $4,500 |
| Gabapentin | 240 | $4,268 |
| Lidocaine | 47 | $4,123 |
Paid to pharmacies, not to this prescriber.
Other medical in New Haven
- Gregory RauNew Haven$211K
- Ryan DonovanNew Haven$75K
- Audrey LastraNew Haven$13K
- Melissa FairbairnNew Haven$11K
- Kyla RedwoodNew Haven$9K
- Anna RodonskiNew Haven$7K
- Michael SchultzNew Haven$5K
- Breana BrehmNew Haven$5K
- Andrew TurczakNew Haven$5K
- Shilpa DesaiStamford$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.